Pulmonary Hypertension in Left Heart Disease (PH-LHD) Differentiation Index
- Pulmonary Hypertension in Left Heart Disease (PH-LHD) Differentiation Index: Explanation and Clinical Context
This calculator integrates non-invasive evidence to help differentiate pulmonary arterial hypertension (PAH) from PH due to left heart disease (PH-LHD). The H2FPEF score (Reddy et al., 2018) estimates HFpEF probability using atrial fibrillation (3), BMI >30 (2), ≥2 antihypertensives (1), age >60 (1), E/e' >9 (1), and PASP >35 (1). Scores ≥6 indicate a high likelihood of HFpEF, which strengthens suspicion for PH-LHD.
The pragmatic PH-LHD signal counts bedside findings associated with postcapillary PH: obesity, diabetes, AF, dyslipidemia, LA dilation, ECG LVH, and prior valvular surgery. It provides clinical gestalt support, not a diagnostic replacement for invasive hemodynamics.
If available, the OPTICS score (≥104) adds strong specificity for postcapillary PH, validated in multiple cohorts.
References:
Reddy YNV, et al. Circulation. 2018;138:861–870.
Jansen SMA, et al. J Am Heart Assoc. 2020;9:e015992.
Vachiéry JL, et al. Eur Respir Rev. 2019.
Al-Omary MS, et al. Hypertension. 2020.
Discussion
No discussions yet. Be the first to comment.
Create Note
Notes are stored privately on your device only. No login required. Nothing is uploaded or shared.